kr215.30
2.00% yesterday
Stockholm, Nov 14, 05:29 pm CET
ISIN
SE0000202624
Symbol
GETI B

Getinge Stock price

kr215.30
+9.20 4.46% 1M
+23.40 12.19% 6M
+33.75 18.59% YTD
+28.35 15.16% 1Y
-28.10 11.54% 3Y
+31.30 17.01% 5Y
+4.60 2.18% 10Y
+110.30 105.05% 20Y
Stockholm, Closing price Fri, Nov 14 2025
-4.40 2.00%
ISIN
SE0000202624
Symbol
GETI B

New AI Insights on Getinge Insights AI Insights on Getinge

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
kr59.8b
Enterprise Value
kr68.4b
Net debt
kr8.6b
Cash
kr2.8b
Shares outstanding
272.4m
Valuation (TTM | estimate)
P/E
28.6 | 18.7
P/S
1.7 | 1.7
EV/Sales
1.9 | 1.9
EV/FCF
21.8
P/B
2.1
Dividends
DPS
kr4.60
Yield 1Y | 5Y
2.1% | 1.7%
Growth 1Y | 5Y
4.5% | 25.1%
Payout 1Y | 3Y
76.5% | 55.2%
Increased
6 Years
Financials (TTM | estimate)
Revenue
kr35.9b | kr36.0b
EBITDA
kr6.0b | kr7.0b
EBIT
kr4.8b | kr4.6b
Net Income
kr2.1b | kr3.1b
Free Cash Flow
kr3.1b
Growth (TTM | estimate)
Revenue
6.7% | 3.5%
EBITDA
39.1% | 24.8%
EBIT
47.7% | 2.5%
Net Income
21.5% | 91.1%
Free Cash Flow
22.3%
Margin (TTM | estimate)
Gross
48.0%
EBITDA
16.7% | 19.5%
EBIT
13.3%
Net
5.7% | 8.7%
Free Cash Flow
8.8%
Financial Health
Equity Ratio
51.6%
Return on Equity
5.0%
ROCE
10.8%
ROIC
8.0%
Debt/Equity
0.4
More
EPS
kr7.5
FCF per Share
kr11.5
Short interest
-
Employees
12k
Rev per Employee
kr2.9m
Show more

Is Getinge a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

Getinge Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Getinge forecast:

7x Buy
50%
6x Hold
43%
1x Sell
7%

Analyst Opinions

14 Analysts have issued a Getinge forecast:

Buy
50%
Hold
43%
Sell
7%

Financial data from Getinge

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
35,855 35,855
7% 7%
100%
- Direct Costs 18,652 18,652
2% 2%
52%
17,203 17,203
12% 12%
48%
- Selling and Administrative Expenses 9,726 9,726
4% 4%
27%
- Research and Development Expense 1,310 1,310
4% 4%
4%
5,995 5,995
39% 39%
17%
- Depreciation and Amortization 1,215 1,215
13% 13%
3%
EBIT (Operating Income) EBIT 4,780 4,780
48% 48%
13%
Net Profit 2,054 2,054
21% 21%
6%

In millions SEK.

Don't miss a Thing! We will send you all news about Getinge directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It engages in supplying of solutions for theaters, intensive care units, sterilization centers and companies and institutions within life science. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden.

Head office Sweden
CEO Mattias Perjos
Employees 11,827
Founded 1990
Website www.getinge.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today